LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

Search

McKesson Corp

Slēgts

SektorsVeselības aprūpe

823.18 1.14

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

811.13

Max

824.74

Galvenie mērījumi

By Trading Economics

Ienākumi

426M

1.2B

Pārdošana

5.3B

103B

P/E

Sektora vidējais

24.935

77.671

EPS

9.86

Dividenžu ienesīgums

0.36

Peļņas marža

1.173

Darbinieki

43,000

EBITDA

212M

1.5B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+14.93% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.36%

2.35%

Nākamais dividenžu datums

2026. g. 2. janv.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-2.8B

99B

Iepriekšējā atvēršanas cena

822.04

Iepriekšējā slēgšanas cena

823.18

Ziņu noskaņojums

By Acuity

37%

63%

120 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

McKesson Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 15. dec. 17:39 UTC

Galvenie tirgus virzītāji

Vanda Pharmaceuticals Rises on FDA Biologics License Application

2025. g. 15. dec. 23:44 UTC

Tirgus saruna

Gold Steady Ahead of U.S. Employment Report -- Market Talk

2025. g. 15. dec. 23:38 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 15. dec. 23:38 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

2025. g. 15. dec. 22:19 UTC

Tirgus saruna

Clean-Energy Project Developers Benefit From 'Deep Buyer Universe' -- Market Talk

2025. g. 15. dec. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 15. dec. 21:42 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Modest Valuation, a Signal for a Warner Bros. Sale -- Barrons.com

2025. g. 15. dec. 21:32 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Modest Valuation, Puts Warner Bros. Discovery in Focus -- Barrons.com

2025. g. 15. dec. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

iRobot Files for Bankruptcy After Amazon Was Forced to Scrap Its Deal to Buy the Roomba Maker -- Barrons.com

2025. g. 15. dec. 21:26 UTC

Iegādes, apvienošanās, pārņemšana

Commercial Metals Completes Acquisition of Foley Products for $1.84B >CMC

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Reserves Right to Make Further Proposal If Circumstances Change

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Does Not Intend to Submit Revised Takeover Proposal For Predictive

2025. g. 15. dec. 21:23 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Notes Predictive Shares Trade at Discount to Value Implied By Perseus Proposal

2025. g. 15. dec. 21:22 UTC

Iegādes, apvienošanās, pārņemšana

Perseus Mining: Believes Revised Robex Merger Inferior to Its Own Takeover Proposal

2025. g. 15. dec. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Commercial Metals Completes Acquisition Of Foley Products Company >CMC

2025. g. 15. dec. 21:15 UTC

Iegādes, apvienošanās, pārņemšana

ServiceNow Completes Acquisition Of Moveworks >NOW

2025. g. 15. dec. 21:00 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

2025. g. 15. dec. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

2025. g. 15. dec. 20:36 UTC

Tirgus saruna

Oil Futures Fall Further on Oversupply Concerns -- Market Talk

2025. g. 15. dec. 20:31 UTC

Tirgus saruna

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

2025. g. 15. dec. 20:27 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

ServiceNow's Acquisition Streak Could Cause Investor Angst -- Market Talk

2025. g. 15. dec. 20:15 UTC

Tirgus saruna

El Buen Fin Helps Lift Mexican November Retail Sales -- Market Talk

2025. g. 15. dec. 19:22 UTC

Tirgus saruna

Gold and Silver Gain to Start Week -- Market Talk

2025. g. 15. dec. 18:37 UTC

Tirgus saruna

Oil Futures Extend Losses On Oversupply Worries -- Market Talk

2025. g. 15. dec. 18:29 UTC

Tirgus saruna

ServiceNow Seen Facing Pressure if Government Budgets Decline -- Market Talk

2025. g. 15. dec. 17:58 UTC

Tirgus saruna

Canada Housing Market In Search Of a Bottom -- Market Talk

2025. g. 15. dec. 17:36 UTC

Tirgus saruna

Canada Data Signal Underlying Price Pressures Persist -- Market Talk

2025. g. 15. dec. 17:36 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 15. dec. 17:36 UTC

Peļņas

Texas Instruments Stock Slips. It Caught a Rare Downgrade From Goldman Sachs. -- Barrons.com

2025. g. 15. dec. 17:30 UTC

Iegādes, apvienošanās, pārņemšana

Cinemark Stock Could Fall Even More If Netflix Buys Warner Bros., Analyst Says -- Barrons.com

Salīdzinājums

Cenas izmaiņa

McKesson Corp Prognoze

Cenas mērķis

By TipRanks

14.93% augšup

Prognoze 12 mēnešiem

Vidējais 935.33 USD  14.93%

Augstākais 1,000 USD

Zemākais 860 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi McKesson Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

15 ratings

13

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

681.92 / 707.28Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

No Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

120 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat